Aspirin Therapy in Diabetes
- 1 January 2004
- journal article
- guideline
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (suppl_1), s72-s73
- https://doi.org/10.2337/diacare.27.2007.s72
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 2002
- Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and RationaleAnnals of Internal Medicine, 2002
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- Aspirin Therapy in DiabetesDiabetes Care, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Aspirin Effects on Mortality and Morbidity in Patients With Diabetes MellitusJama-Journal Of The American Medical Association, 1992
- Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS InvestigatorsJAMA, 1992
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyThe New England Journal of Medicine, 1989